Health Bulletin 29/October/2022

Here are the top health news for the day:

NMC warns against Illegal MBBS and other medical courses at Singhania University

Taking serious cognizance of the unpermitted MBBS and other medical courses being offered by Singhania University this academic year, the National Medical Commission (NMC) has issued an alert warning medical aspirants about the varsity's mischievious claim.

The warning is pursuant to the recent advertisement published by Singhania University, Pacheri Bari, Distt. Jhunjhunu, Rajasthan, inviting applications for MBBS and other medical courses. The institution has in its advertisement published in various newspapers claimed that the Hon'ble High Court in the case of IGNOU has held that there is no provision in the Indian Medical Council Act which authorises and empowers BoG-MCI to grant permission or recognition to IGNOU to enable it to take admission and impart education in MBBS and other medical courses.    

For more details, check out the link given below:

NMC Warns Against Illegal MBBS And Other Medical Courses At Singhania University

Brain stroke cases increasing in younger population

Brain stroke has long been considered a disease of the elderly, but recent data suggests it is now commonly occurring in young population in India as well. The occurrence of stroke in young adults is particularly concerning as these patients in the prime of their life are often affected by physical disability, depression, cognitive impairment, and loss of productivity, all of which have serious personal, social, and economic implications. This was said by doctors of Amrita Hospital, Faridabad, (Dr. Sanjay Pandey, Dr. Amit Kumar Agarwal and Dr. Deepak Yadav) on occasion of the World Stroke Day 2022.

Talking about the rising incidence of stroke in India in lower age groups, Dr. Sanjay Pandey, Head, Dept. of Neurology, Amrita Hospital, Faridabad, said: "Stroke is the second most common cause of death and the third-leading cause of death and disability combined in the world. So, it is a matter of serious concern that it is no longer a disease of the elderly in our country. A hospital-based study from India has shown that the proportion of strokes in young people now ranges from 15-30%. In another population-based study in the country, 8.8% of total stroke patients were found to belong to the younger age group."

For more health news, check out official site of Medical Dialogues:

https://medicaldialogues.in/

NPPA panel suggests retail price of Atorvastatin, Bempedoic acid FDC marketed by Zydus Healthcare

The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each film coated tablet containing Atorvastatin Calcium equivalent, Atorvastatin 80mg and Bempedoic Acid 180mg marketed by Zydus Healthcare Limited at Rs. 50.71 per tablet excluding GST.

This recommendation came during the 48th meeting of the Multidisciplinary Committee of Experts, held on October 19, 2022, under the convenorship of Shri Manmohan Sachdeva , Advisor(cost), through video conferencing, where the issue of retail price fixation of Atorvastatin Calcium equivalent Atorvastatin 80mg and Bempedoic Acid 180mg manufactured by Exemed Pharmaceutical and marketed by Zydus Healthcare Limited under Para 5 DPCO, 2013 was analysed.

For more details, check out the link given below:

NPPA Panel Suggests Retail Price Of Atorvastatin, Bempedoic Acid FDC Marketed By Zydus Healthcare